1 Study Coverage 1.1 Endometriosis Product Introduction 1.2 Market by Type 1.2.1 Global Endometriosis Market Size Growth Rate by Type 1.2.2 Gonadotropins Releasing Hormone Agonists 1.2.3 Non-Steroidal Anti-Inflammatory Drugs 1.2.4 Progestin 1.2.5 Oral Contraceptive Pills 1.3 Market by Application 1.3.1 Global Endometriosis Market Size Growth Rate by Application 1.3.2 Hospital Use 1.3.3 Clinic Use 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Endometriosis Market Size, Estimates and Forecasts 2.1.1 Global Endometriosis Revenue 2016-2027 2.1.2 Global Endometriosis Sales 2016-2027 2.2 Global Endometriosis, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Endometriosis Historical Market Size by Region (2016-2021) 2.3.1 Global Endometriosis Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Endometriosis Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Endometriosis Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Endometriosis Sales Forecast by Region (2022-2027) 2.4.2 Global Endometriosis Revenue Forecast by Region (2022-2027) 3 Global Endometriosis Competitor Landscape by Players 3.1 Global Top Endometriosis Manufacturers by Sales 3.1.1 Global Endometriosis Sales by Manufacturer (2016-2021) 3.1.2 Global Endometriosis Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Endometriosis Manufacturers by Revenue 3.2.1 Key Endometriosis Manufacturers Covered: Ranking by Revenue 3.2.2 Global Endometriosis Revenue by Manufacturers (2016-2021) 3.2.3 Global Endometriosis Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Endometriosis Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Endometriosis Revenue in 2020 3.2.6 Global Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Endometriosis Price by Manufacturers 3.4 Global Endometriosis Manufacturing Base Distribution, Product Types 3.4.1 Endometriosis Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Endometriosis Product Type 3.4.3 Date of International Manufacturers Enter into Endometriosis Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Endometriosis Market Size by Type (2016-2021) 4.1.1 Global Endometriosis Sales by Type (2016-2021) 4.1.2 Global Endometriosis Revenue by Type (2016-2021) 4.1.3 Endometriosis Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Endometriosis Market Size Forecast by Type (2022-2027) 4.2.1 Global Endometriosis Sales Forecast by Type (2022-2027) 4.2.2 Global Endometriosis Revenue Forecast by Type (2022-2027) 4.2.3 Endometriosis Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Endometriosis Market Size by Application (2016-2021) 5.1.1 Global Endometriosis Sales by Application (2016-2021) 5.1.2 Global Endometriosis Revenue by Application (2016-2021) 5.1.3 Endometriosis Price by Application (2016-2021) 5.2 Endometriosis Market Size Forecast by Application (2022-2027) 5.2.1 Global Endometriosis Sales Forecast by Application (2022-2027) 5.2.2 Global Endometriosis Revenue Forecast by Application (2022-2027) 5.2.3 Global Endometriosis Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Endometriosis Market Size YoY Growth 2016-2027 6.1.1 China Endometriosis Sales YoY Growth 2016-2027 6.1.2 China Endometriosis Revenue YoY Growth 2016-2027 6.1.3 China Endometriosis Market Share in Global Market 2016-2027 6.2 China Endometriosis Market Size by Players (International and Local Players) 6.2.1 China Top Endometriosis Players by Sales (2016-2021) 6.2.2 China Top Endometriosis Players by Revenue (2016-2021) 6.3 China Endometriosis Historic Market Review by Type (2016-2021) 6.3.1 China Endometriosis Sales Market Share by Type (2016-2021) 6.3.2 China Endometriosis Revenue Market Share by Type (2016-2021) 6.3.3 China Endometriosis Price by Type (2016-2021) 6.4 China Endometriosis Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Endometriosis Sales Forecast by Type (2022-2027) 6.4.2 China Endometriosis Revenue Forecast by Type (2022-2027) 6.4.3 China Endometriosis Price Forecast by Type (2022-2027) 6.5 China Endometriosis Historic Market Review by Application (2016-2021) 6.5.1 China Endometriosis Sales Market Share by Application (2016-2021) 6.5.2 China Endometriosis Revenue Market Share by Application (2016-2021) 6.5.3 China Endometriosis Price by Application (2016-2021) 6.6 China Endometriosis Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Endometriosis Sales Forecast by Application (2022-2027) 6.6.2 China Endometriosis Revenue Forecast by Application (2022-2027) 6.6.3 China Endometriosis Price Forecast by Application (2022-2027) 7 North America 7.1 North America Endometriosis Market Size YoY Growth 2016-2027 7.2 North America Endometriosis Market Facts & Figures by Country 7.2.1 North America Endometriosis Sales by Country (2016-2021) 7.2.2 North America Endometriosis Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Endometriosis Market Size YoY Growth 2016-2027 8.2 Asia Pacific Endometriosis Market Facts & Figures by Region 8.2.1 Asia Pacific Endometriosis Sales by Region (2016-2021) 8.2.2 Asia Pacific Endometriosis Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Endometriosis Market Size YoY Growth 2016-2027 9.2 Europe Endometriosis Market Facts & Figures by Country 9.2.1 Europe Endometriosis Sales by Country (2016-2021) 9.2.2 Europe Endometriosis Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Endometriosis Market Size YoY Growth 2016-2027 10.2 Latin America Endometriosis Market Facts & Figures by Country 10.2.1 Latin America Endometriosis Sales by Country (2016-2021) 10.2.2 Latin America Endometriosis Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Endometriosis Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Endometriosis Market Facts & Figures by Country 11.2.1 Middle East and Africa Endometriosis Sales by Country (2016-2021) 11.2.2 Middle East and Africa Endometriosis Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 AbbVie 12.1.1 AbbVie Corporation Information 12.1.2 AbbVie Description and Business Overview 12.1.3 AbbVie Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.1.4 AbbVie Endometriosis Products Offered 12.1.5 AbbVie Recent Development 12.2 AstraZeneca 12.2.1 AstraZeneca Corporation Information 12.2.2 AstraZeneca Description and Business Overview 12.2.3 AstraZeneca Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.2.4 AstraZeneca Endometriosis Products Offered 12.2.5 AstraZeneca Recent Development 12.3 Bayer HealthCare 12.3.1 Bayer HealthCare Corporation Information 12.3.2 Bayer HealthCare Description and Business Overview 12.3.3 Bayer HealthCare Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Bayer HealthCare Endometriosis Products Offered 12.3.5 Bayer HealthCare Recent Development 12.4 Pfizer 12.4.1 Pfizer Corporation Information 12.4.2 Pfizer Description and Business Overview 12.4.3 Pfizer Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Pfizer Endometriosis Products Offered 12.4.5 Pfizer Recent Development 12.5 Addex Therapeutics 12.5.1 Addex Therapeutics Corporation Information 12.5.2 Addex Therapeutics Description and Business Overview 12.5.3 Addex Therapeutics Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Addex Therapeutics Endometriosis Products Offered 12.5.5 Addex Therapeutics Recent Development 12.6 Astellas Pharma 12.6.1 Astellas Pharma Corporation Information 12.6.2 Astellas Pharma Description and Business Overview 12.6.3 Astellas Pharma Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Astellas Pharma Endometriosis Products Offered 12.6.5 Astellas Pharma Recent Development 12.7 Debiopharm 12.7.1 Debiopharm Corporation Information 12.7.2 Debiopharm Description and Business Overview 12.7.3 Debiopharm Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Debiopharm Endometriosis Products Offered 12.7.5 Debiopharm Recent Development 12.8 ElexoPharm 12.8.1 ElexoPharm Corporation Information 12.8.2 ElexoPharm Description and Business Overview 12.8.3 ElexoPharm Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.8.4 ElexoPharm Endometriosis Products Offered 12.8.5 ElexoPharm Recent Development 12.9 EndoCeutics 12.9.1 EndoCeutics Corporation Information 12.9.2 EndoCeutics Description and Business Overview 12.9.3 EndoCeutics Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.9.4 EndoCeutics Endometriosis Products Offered 12.9.5 EndoCeutics Recent Development 12.10 Euroscreen 12.10.1 Euroscreen Corporation Information 12.10.2 Euroscreen Description and Business Overview 12.10.3 Euroscreen Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Euroscreen Endometriosis Products Offered 12.10.5 Euroscreen Recent Development 12.11 AbbVie 12.11.1 AbbVie Corporation Information 12.11.2 AbbVie Description and Business Overview 12.11.3 AbbVie Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.11.4 AbbVie Endometriosis Products Offered 12.11.5 AbbVie Recent Development 12.12 Kissei Pharmaceutical 12.12.1 Kissei Pharmaceutical Corporation Information 12.12.2 Kissei Pharmaceutical Description and Business Overview 12.12.3 Kissei Pharmaceutical Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Kissei Pharmaceutical Products Offered 12.12.5 Kissei Pharmaceutical Recent Development 12.13 Neurocrine Biosciences 12.13.1 Neurocrine Biosciences Corporation Information 12.13.2 Neurocrine Biosciences Description and Business Overview 12.13.3 Neurocrine Biosciences Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.13.4 Neurocrine Biosciences Products Offered 12.13.5 Neurocrine Biosciences Recent Development 12.14 Nippon Shinyaku 12.14.1 Nippon Shinyaku Corporation Information 12.14.2 Nippon Shinyaku Description and Business Overview 12.14.3 Nippon Shinyaku Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.14.4 Nippon Shinyaku Products Offered 12.14.5 Nippon Shinyaku Recent Development 12.15 Takeda 12.15.1 Takeda Corporation Information 12.15.2 Takeda Description and Business Overview 12.15.3 Takeda Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Takeda Products Offered 12.15.5 Takeda Recent Development 12.16 Bayer AG 12.16.1 Bayer AG Corporation Information 12.16.2 Bayer AG Description and Business Overview 12.16.3 Bayer AG Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Bayer AG Products Offered 12.16.5 Bayer AG Recent Development 12.17 Neurocrine Biosciences 12.17.1 Neurocrine Biosciences Corporation Information 12.17.2 Neurocrine Biosciences Description and Business Overview 12.17.3 Neurocrine Biosciences Endometriosis Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Neurocrine Biosciences Products Offered 12.17.5 Neurocrine Biosciences Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Endometriosis Industry Trends 13.2 Endometriosis Market Drivers 13.3 Endometriosis Market Challenges 13.4 Endometriosis Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Endometriosis Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Endometriosis Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Gonadotropins Releasing Hormone Agonists Table 3. Major Manufacturers of Non-Steroidal Anti-Inflammatory Drugs Table 4. Major Manufacturers of Progestin Table 5. Major Manufacturers of Oral Contraceptive Pills Table 6. Global Endometriosis Market Size Growth Rate by Application (2021-2027) & (K Units) Table 7. Global Endometriosis Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 8. Global Endometriosis Sales by Regions (2016-2021) & (K Units) Table 9. Global Endometriosis Sales Market Share by Regions (2016-2021) Table 10. Global Endometriosis Revenue by Regions (2016-2021) & (US$ Million) Table 11. Global Endometriosis Sales Forecast by Region (2022-2027) & (K Units) Table 12. Global Endometriosis Sales Market Share Forecast by Region (2022-2027) Table 13. Global Endometriosis Revenue Forecast by Region (2022-2027) & (US$ Million) Table 14. Global Endometriosis Revenue Market Share Forecast by Region (2022-2027) Table 15. Global Endometriosis Sales by Manufacturers (2016-2021) (K Units) Table 16. Global Endometriosis Sales Share by Manufacturers (2016-2021) Table 17. Ranking of Global Top Endometriosis Manufacturers by Revenue (US$ Million) in 2020 Table 18. Endometriosis Revenue by Manufacturers (2016-2021) (US$ Million) Table 19. Endometriosis Revenue Share by Manufacturers (2016-2021) Table 20. Global Endometriosis Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 21. Global Endometriosis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis as of 2020) Table 22. Key Manufacturers Endometriosis Price (2016-2021) (USD/Unit) Table 23. Endometriosis Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Endometriosis Product Type Table 25. Date of International Manufacturers Enter into Endometriosis Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Endometriosis Sales by Type (2016-2021) (K Units) Table 28. Global Endometriosis Sales Share by Type (2016-2021) Table 29. Global Endometriosis Revenue by Type (2016-2021) (US$ Million) Table 30. Global Endometriosis Revenue Share by Type (2016-2021) Table 31. Endometriosis Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit) Table 32. Global Endometriosis Sales Forecast by Type (2022-2027) & (K Units) Table 33. Global Endometriosis Sales Market Share Forecast by Type (2022-2027) Table 34. Global Endometriosis Revenue Forecast V (2022-2027) & (US$ Million) Table 35. Global Endometriosis Revenue Market Share Forecast by Type (2022-2027) Table 36. Global Endometriosis Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit) Table 37. Global Endometriosis Sales by Application (2016-2021) (K Units) Table 38. Global Endometriosis Sales Share by Application (2016-2021) Table 39. Global Endometriosis Revenue by Application (2016-2021) (US$ Million) Table 40. Global Endometriosis Revenue Share by Application (2016-2021) Table 41. Endometriosis Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit) Table 42. Global Endometriosis Sales Forecast by Application (2022-2027) & (K Units) Table 43. Global Endometriosis Sales Market Share Forecast by Application (2022-2027) Table 44. Global Endometriosis Revenue Forecast by Application (2022-2027) & (US$ Million) Table 45. Global Endometriosis Revenue Market Share Forecast by Application (2022-2027) Table 46. Global Endometriosis Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit) Table 47. China Endometriosis Sales (K Units) of Key Companies (2016-2021) Table 48. China Endometriosis Sales Share by Company (2016-2021) Table 49. China Endometriosis Revenue (US$ Million) by Company (2016-2021) Table 50. China Endometriosis Revenue Share by Company (2016-2021) Table 51. China Endometriosis Sales (K Units) by Type (2016-2021) Table 52. China Endometriosis Sales Share by Type (2016-2021) Table 53. China Endometriosis Revenue (US$ Million) Market Share by Type (2016-2021) Table 54. China Endometriosis Price (USD/Unit) by Type (2016-2021) Table 55. China Endometriosis Sales (K Units) by Type (2022-2027) Table 56. China Endometriosis Sales Share by Type (2022-2027) Table 57. China Endometriosis Revenue (US$ Million) Market Share by Type (2022-2027) Table 58. China Endometriosis Revenue Share by Type (2022-2027) Table 59. China Endometriosis Price (USD/Unit) by Type (2022-2027) Table 60. China Endometriosis Sales (K Units) by Application (2016-2021) Table 61. China Endometriosis Sales Share by Application (2016-2021) Table 62. China Endometriosis Revenue (US$ Million) Market Share by Application (2016-2021) Table 63. China Endometriosis Price (USD/Unit) by Application (2016-2021) Table 64. China Endometriosis Sales (K Units) by Application (2022-2027) Table 65. China Endometriosis Sales Share by Application (2022-2027) Table 66. China Endometriosis Revenue (US$ Million) Market Share by Application (2022-2027) Table 67. China Endometriosis Revenue Share by Application (2022-2027) Table 68. China Endometriosis Price (USD/Unit) by Application (2022-2027) Table 69. North America Endometriosis Sales by Country (2016-2021) & (K Units) Table 70. North America Endometriosis Sales Market Share by Country (2016-2021) Table 71. North America Endometriosis Revenue by Country (2016-2021) & (US$ Million) Table 72. North America Endometriosis Revenue Market Share by Country (2016-2021) Table 73. Asia Pacific Endometriosis Sales by Region (2016-2021) & (K Units) Table 74. Asia Pacific Endometriosis Sales Market Share by Region (2016-2021) Table 75. Asia Pacific Endometriosis Revenue by Region (2016-2021) & (US$ Million) Table 76. Asia Pacific Endometriosis Revenue Market Share by Region (2016-2021) Table 77. Europe Endometriosis Sales by Country (2016-2021) & (K Units) Table 78. Europe Endometriosis Sales Market Share by Country (2016-2021) Table 79. Europe Endometriosis Revenue by Country (2016-2021) & (US$ Million) Table 80. Europe Endometriosis Revenue Market Share by Country (2016-2021) Table 81. Latin America Endometriosis Sales by Country (2016-2021) & (K Units) Table 82. Latin America Endometriosis Sales Market Share by Country (2016-2021) Table 83. Latin Americaa Endometriosis Revenue by Country (2016-2021) & (US$ Million) Table 84. Latin America Endometriosis Revenue Market Share by Country (2016-2021) Table 85. Middle East and Africa Endometriosis Sales by Country (2016-2021) & (K Units) Table 86. Middle East and Africa Endometriosis Sales Market Share by Country (2016-2021) Table 87. Middle East and Africa Endometriosis Revenue by Country (2016-2021) & (US$ Million) Table 88. Middle East and Africa Endometriosis Revenue Market Share by Country (2016-2021) Table 89. AbbVie Corporation Information Table 90. AbbVie Description and Business Overview Table 91. AbbVie Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 92. AbbVie Endometriosis Product Table 93. AbbVie Recent Development Table 94. AstraZeneca Corporation Information Table 95. AstraZeneca Description and Business Overview Table 96. AstraZeneca Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 97. AstraZeneca Product Table 98. AstraZeneca Recent Development Table 99. Bayer HealthCare Corporation Information Table 100. Bayer HealthCare Description and Business Overview Table 101. Bayer HealthCare Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 102. Bayer HealthCare Product Table 103. Bayer HealthCare Recent Development Table 104. Pfizer Corporation Information Table 105. Pfizer Description and Business Overview Table 106. Pfizer Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 107. Pfizer Product Table 108. Pfizer Recent Development Table 109. Addex Therapeutics Corporation Information Table 110. Addex Therapeutics Description and Business Overview Table 111. Addex Therapeutics Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 112. Addex Therapeutics Product Table 113. Addex Therapeutics Recent Development Table 114. Astellas Pharma Corporation Information Table 115. Astellas Pharma Description and Business Overview Table 116. Astellas Pharma Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 117. Astellas Pharma Product Table 118. Astellas Pharma Recent Development Table 119. Debiopharm Corporation Information Table 120. Debiopharm Description and Business Overview Table 121. Debiopharm Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 122. Debiopharm Product Table 123. Debiopharm Recent Development Table 124. ElexoPharm Corporation Information Table 125. ElexoPharm Description and Business Overview Table 126. ElexoPharm Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 127. ElexoPharm Product Table 128. ElexoPharm Recent Development Table 129. EndoCeutics Corporation Information Table 130. EndoCeutics Description and Business Overview Table 131. EndoCeutics Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 132. EndoCeutics Product Table 133. EndoCeutics Recent Development Table 134. Euroscreen Corporation Information Table 135. Euroscreen Description and Business Overview Table 136. Euroscreen Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 137. Euroscreen Product Table 138. Euroscreen Recent Development Table 139. Forendo Pharma Corporation Information Table 140. Forendo Pharma Description and Business Overview Table 141. Forendo Pharma Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 142. Forendo Pharma Product Table 143. Forendo Pharma Recent Development Table 144. Kissei Pharmaceutical Corporation Information Table 145. Kissei Pharmaceutical Description and Business Overview Table 146. Kissei Pharmaceutical Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 147. Kissei Pharmaceutical Product Table 148. Kissei Pharmaceutical Recent Development Table 149. Neurocrine Biosciences Corporation Information Table 150. Neurocrine Biosciences Description and Business Overview Table 151. Neurocrine Biosciences Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 152. Neurocrine Biosciences Product Table 153. Neurocrine Biosciences Recent Development Table 154. Nippon Shinyaku Corporation Information Table 155. Nippon Shinyaku Description and Business Overview Table 156. Nippon Shinyaku Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 157. Nippon Shinyaku Product Table 158. Nippon Shinyaku Recent Development Table 159. Takeda Corporation Information Table 160. Takeda Description and Business Overview Table 161. Takeda Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 162. Takeda Product Table 163. Takeda Recent Development Table 164. Bayer AG Corporation Information Table 165. Bayer AG Description and Business Overview Table 166. Bayer AG Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 167. Bayer AG Product Table 168. Bayer AG Recent Development Table 169. Neurocrine Biosciences Corporation Information Table 170. Neurocrine Biosciences Description and Business Overview Table 171. Neurocrine Biosciences Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021) Table 172. Neurocrine Biosciences Product Table 173. Neurocrine Biosciences Recent Development Table 174. Endometriosis Market Trends Table 175. Endometriosis Market Drivers Table 176. Endometriosis Market Challenges Table 177. Endometriosis Market Restraints Table 178. Endometriosis Customers List Table 179. Endometriosis Distributors List Table 180. Research Programs/Design for This Report Table 181. Key Data Information from Secondary Sources Table 182. Key Data Information from Primary Sources List of Figures Figure 1. Endometriosis Product Picture Figure 2. Global Endometriosis Sales Market Share by Type in 2020 & 2027 Figure 3. Gonadotropins Releasing Hormone Agonists Product Picture Figure 4. Non-Steroidal Anti-Inflammatory Drugs Product Picture Figure 5. Progestin Product Picture Figure 6. Oral Contraceptive Pills Product Picture Figure 7. Global Endometriosis Sales Market Share by Application in 2020 & 2027 Figure 8. Hospital Use Figure 9. Clinic Use Figure 10. Other Figure 11. Endometriosis Report Years Considered Figure 12. Global Endometriosis Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Endometriosis Market Size 2016-2027 (US$ Million) Figure 14. Global Endometriosis Sales 2016-2027 (K Units) Figure 15. Global Endometriosis Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Endometriosis Sales Market Share by Region (2016-2021) Figure 17. Global Endometriosis Sales Market Share by Region in 2020 Figure 18. Global Endometriosis Revenue Market Share by Region (2016-2021) Figure 19. Global Endometriosis Revenue Market Share by Region in 2020 Figure 20. Global Endometriosis Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Endometriosis Revenue in 2020 Figure 22. Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Endometriosis Sales Market Share by Type (2016-2021) Figure 24. Global Endometriosis Sales Market Share by Type in 2020 Figure 25. Global Endometriosis Revenue Market Share by Type (2016-2021) Figure 26. Global Endometriosis Revenue Market Share by Type in 2020 Figure 27. Global Endometriosis Sales Market Share by Application (2016-2021) Figure 28. Global Endometriosis Sales Market Share by Application in 2020 Figure 29. Global Endometriosis Revenue Market Share by Application (2016-2021) Figure 30. Global Endometriosis Revenue Market Share by Application in 2020 Figure 31. China Endometriosis Sales Growth Rate 2016-2027 (K Units) Figure 32. China Endometriosis Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. China Endometriosis Market Share in Global Market 2016-2027 Figure 34. China 5 and 10 Largest Endometriosis Players Market Share by Revenue in Endometriosis in 2020 Figure 35. China Endometriosis Revenue Share by Type (2016-2021) Figure 36. China Endometriosis Revenue Growth Rate by Type in 2016 & 2020 Figure 37. China Endometriosis Revenue Share by Application (2016-2021) Figure 38. China Endometriosis Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Endometriosis Sales Growth Rate 2016-2021 (K Units) Figure 40. North America Endometriosis Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Endometriosis Sales Market Share by Country in 2020 Figure 42. North America Endometriosis Revenue Market Share by Country in 2020 Figure 43. U.S. Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 44. U.S. Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 46. Canada Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Endometriosis Sales Growth Rate 2016-2021 (K Units) Figure 48. Europe Endometriosis Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Endometriosis Sales Market Share by Country in 2020 Figure 50. Europe Endometriosis Revenue Market Share by Country in 2020 Figure 51. Germany Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 52. Germany Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 54. France Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 56. U.K. Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 58. Italy Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 60. Russia Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Endometriosis Sales Growth Rate 2016-2021 (K Units) Figure 62. Asia Pacific Endometriosis Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Endometriosis Sales Market Share by Region in 2020 Figure 64. Asia Pacific Endometriosis Revenue Market Share by Region in 2020 Figure 65. China Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 66. China Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 68. Japan Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 70. South Korea Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 72. India Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 74. Australia Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 76. Taiwan Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 78. Indonesia Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 80. Thailand Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 82. Malaysia Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 84. Philippines Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 86. Vietnam Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Endometriosis Sales Growth Rate 2016-2021 (K Units) Figure 88. Latin America Endometriosis Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Endometriosis Sales Market Share by Country in 2020 Figure 90. Latin America Endometriosis Revenue Market Share by Country in 2020 Figure 91. Mexico Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 92. Mexico Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 94. Brazil Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 96. Argentina Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Endometriosis Sales Growth Rate 2016-2021 (K Units) Figure 98. Middle East and Africa Endometriosis Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Endometriosis Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Endometriosis Revenue Market Share by Country in 2020 Figure 101. Turkey Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 102. Turkey Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 104. Saudi Arabia Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. U.A.E Endometriosis Sales Growth Rate (2016-2021) (K Units) Figure 106. U.A.E Endometriosis Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Endometriosis Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

AbbVie AstraZeneca Bayer HealthCare Pfizer Addex Therapeutics Astellas Pharma Debiopharm ElexoPharm EndoCeutics Euroscreen Forendo Pharma Kissei Pharmaceutical Neurocrine Biosciences Nippon Shinyaku Takeda Bayer AG Neurocrine Biosciences